FDA Plan to Combat Opioid Epidemic Highlights AJPB Week in Review

5. Brain Glucose Levels Drop in Patients with Obesity, Diabetes

Low brain glucose levels may result in overeating among patients with obesity and type 2 diabetes. Read more.

4. FDA Grants Accelerated Approval to Acalabrutinib for Mantle Cell Lymphoma

Calquence is a kinase inhibitor that blocks an enzyme crucial for cancer growth. Read more.

3. CVS Launches New Performance-Based PBM Network

New network encourages medication adherence for chronic conditions. Read more.

2. Novartis Seeks New Indication for Gene Therapy Kymriah

Tisagenlecleucel (Kyrmiah) shows promise as a treatment for diffuse large B-cell lymphoma. Read more.

1. FDA Highlights New Strategies to Combat the Opioid Epidemic

Novel methods to package, store, and dispose of opioids could fight the ongoing epidemic. Read more.